GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novan Inc (OTCPK:NOVNW) » Definitions » Shares Outstanding (Basic Average)

Novan (NOVNW) Shares Outstanding (Basic Average) : 0.00 Mil (As of Mar. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Novan Shares Outstanding (Basic Average)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Novan's average basic shares outstanding for the quarter that ended in Mar. 2023 was 0.00 Mil.


Novan Shares Outstanding (Basic Average) Historical Data

The historical data trend for Novan's Shares Outstanding (Basic Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novan Shares Outstanding (Basic Average) Chart

Novan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shares Outstanding (Basic Average)
Get a 7-Day Free Trial Premium Member Only - - - - -

Novan Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Shares Outstanding (Basic Average) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Novan Shares Outstanding (Basic Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Novan  (OTCPK:NOVNW) Shares Outstanding (Basic Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.


Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Novan Shares Outstanding (Basic Average) Related Terms

Thank you for viewing the detailed overview of Novan's Shares Outstanding (Basic Average) provided by GuruFocus.com. Please click on the following links to see related term pages.


Novan Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novan Inc (OTCPK:NOVNW) » Definitions » Shares Outstanding (Basic Average)
Traded in Other Exchanges
N/A
Address
P.O. Box 64, Pittsboro, NC, USA, 27312
NVN Liquidation Inc Formerly Novan Inc is a dermatology company focused on developing and commercializing therapeutic products for skin diseases. It is developing SB206 as a topical prescription gel for the treatment of viral skin infections. The company's product portfolio includes; Wynzora Cream for the treatment of plaque psoriasis, Rhofade cream for the treatment of persistent facial erythema, Minolira tablets to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients, Cloderm cream for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, Sitavig tablets for the treatment of recurrent herpes labialis in immunocompetent adults, and Nuvail nail solution for managing signs and symptoms of nail dystrophy.

Novan Headlines

From GuruFocus

Q1 2023 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Novan Focuses Strategic Direction and Announces Restructuring

By sperokesalga sperokesalga 05-31-2023

Novan Announces Closing of $6.0 Million Registered Direct Offering

By sperokesalga sperokesalga 03-17-2023

Novan Inc To Host Corporate Update Call Transcript

By GuruFocus Research 02-14-2024

Novan, Inc. - Special Call Transcript

By GuruFocus Research 02-14-2024

Q4 2021 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Novan Inc To Acquire EPI Health LLC Call Transcript

By GuruFocus Research 02-14-2024

Novan Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Novan Inc SB206 Clinical Data Update Call Transcript

By GuruFocus Research 02-14-2024